Under this collaboration, AstraZeneca will gain access to Syneron Bio's innovative Synova™ platform, an intelligent and high-throughput macrocyclic peptide drug research and development platform, designed to support the advancements of research programmes exploring possible future treatments of chronic diseases.
Leeford is actively expanding its presence in the Core Critical Care segment with the establishment of our own injectable manufacturing unit, said Amit Gupta, MD & Chairman, Leeford Healthcare in an interview wi...
Our high-speed doors are designed with advanced sensors and automated control systems, allowing them to adapt to changing environmental conditions in real-time, states Bobby Abhishek Madaan, Director, Toshi Automati...
Freudenberg’s leadership emphasized India’s strategic importance in their global expansion plans. With the country’s pharmaceutical market growing at a CAGR of 12 percent, the company is committed ...
Research indicates that businesses with women in high-ranking positions often enjoy greater profitability and stronger financial success....
Only 2 of the 53 critical APIs have 60 percent of their requirements met by domestic suppliers along with the price difference compared to imports exceeding 20 percent....
KPO service providers optimise the pharmaceutical value chain by performing specialized and knowledge-driven tasks....
Latest news in...
Keywords
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy